Nisa Investment Advisors LLC Lowers Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Nisa Investment Advisors LLC trimmed its position in Pediatrix Medical Group, Inc. (NYSE:MD) by 36.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,130 shares of the company’s stock after selling 1,825 shares during the period. Nisa Investment Advisors LLC’s holdings in Pediatrix Medical Group were worth $29,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Pacer Advisors Inc. increased its position in Pediatrix Medical Group by 126.9% during the 4th quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after purchasing an additional 1,809,828 shares during the period. Envestnet Asset Management Inc. lifted its holdings in Pediatrix Medical Group by 250.6% in the third quarter. Envestnet Asset Management Inc. now owns 267,434 shares of the company’s stock valued at $3,399,000 after acquiring an additional 191,154 shares during the period. AQR Capital Management LLC boosted its position in shares of Pediatrix Medical Group by 43.7% during the 3rd quarter. AQR Capital Management LLC now owns 559,879 shares of the company’s stock worth $7,116,000 after purchasing an additional 170,375 shares in the last quarter. Trexquant Investment LP acquired a new position in shares of Pediatrix Medical Group during the 3rd quarter worth $1,078,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Pediatrix Medical Group by 4.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,485,465 shares of the company’s stock valued at $18,880,000 after purchasing an additional 57,193 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock opened at $9.03 on Tuesday. Pediatrix Medical Group, Inc. has a 1 year low of $7.70 and a 1 year high of $15.06. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24. The business has a 50 day moving average price of $9.20 and a 200 day moving average price of $9.67. The company has a market capitalization of $758.79 million, a P/E ratio of -12.37, a P/E/G ratio of 2.44 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings results on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $496.44 million during the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The business’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.46 earnings per share. Sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.12 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on MD shares. Mizuho decreased their price objective on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Wednesday, February 21st. Truist Financial dropped their price objective on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research note on Wednesday, February 21st. Jefferies Financial Group decreased their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Finally, TheStreet cut Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Five equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $10.30.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.